PI3K and cancer: lessons, challenges and opportunities

David A. Fruman(University of California, Irvine), Christian Rommel(Amgen (United States))

Nature Reviews Drug Discovery

January 31, 2014

10.1038/nrd4204

Cited by 1,724

Abstract

Related Papers

Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)

Sven Zimmermann, Karin Moelling|Science|1999|1.1k

Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002.

G.J. Brunn, Josie M. Williams, Candace J. Sabers et al.|The EMBO Journal|1996|723

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

Shijie Li, Michael S. Brown, Joseph L. Goldstein|Proceedings of the National Academy of Sciences|2010|718

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

Massimo Ammirante, Jun‐Li Luo, Sergei I. Grivennikov et al.|Nature|2010|635

The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

Chuan‐Hsiang Huang, Diana Mandelker, Oleg Schmidt‐Kittler et al.|Science|2007|558